Ovarian Tumor of Low Malignant Potential
📧 Sign up to get email alerts when something new happens for Ovarian Tumor of Low Malignant Potential.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in patients with refractory or relapsed ovarian epithelial cancer, fallopian tube…